141 related articles for article (PubMed ID: 9142972)
1. Second-line endocrine treatment of advanced breast cancer--a randomized cross-over study of medroxy-progesterone acetate and aminoglutethimide.
Hultborn R; Johansson-Terje I; Bergh J; Glas U; Hallsten L; Hatschek T; Holmberg E; Ideström K; Norberg B; Ranstam J; Söderberg M; Wallgren UB
Acta Oncol; 1996; 35 Suppl 5():75. PubMed ID: 9142972
[No Abstract] [Full Text] [Related]
2. [Megestrol acetate as hormone therapy in oncology].
Berstein LM
Vopr Onkol; 1998; 44(2):142-8. PubMed ID: 9615815
[TBL] [Abstract][Full Text] [Related]
3. [Changes in serum lipoproteins under hormonal therapy of breast carcinoma and other endocrine-dependent tumors].
Wander HE; Teichmann AT; Cremer P; Wieland H; Kruse B; Nagel GA; Kuhn W; Seidel D
Onkologie; 1985 Apr; 8(2):88-92. PubMed ID: 3158861
[TBL] [Abstract][Full Text] [Related]
4. Endocrine treatment of advanced breast cancer.
Dowsett M
Acta Oncol; 1996; 35 Suppl 5():68-72. PubMed ID: 9142970
[TBL] [Abstract][Full Text] [Related]
5. Management of breast cancer with bone metastases.
Clavel M
Bone; 1991; 12 Suppl 1():S11-2. PubMed ID: 1720011
[No Abstract] [Full Text] [Related]
6. [Aminoglutethimide plus high-dose medroxyprogesterone acetate versus aminoglutethimide plus cortisone in therapy of metastasizing breast cancer. An AIO phase III study].
Wander HE; Kleeberg UR; Essers U; Blossey HC; Nagel GA
Onkologie; 1987 Oct; 10(5):321-3. PubMed ID: 2960938
[No Abstract] [Full Text] [Related]
7. [Value of hormone therapy in metastasizing breast cancer].
Samonigg H
Wien Med Wochenschr; 1985 Dec; 135(23-24):602-7. PubMed ID: 2937208
[TBL] [Abstract][Full Text] [Related]
8. On the role of additive hormone monotherapy with tamoxifen, medroxyprogesterone acetate and aminoglutethimide, in advanced breast cancer.
Petru E; Schmähl D
Klin Wochenschr; 1987 Oct; 65(20):959-66. PubMed ID: 2963170
[TBL] [Abstract][Full Text] [Related]
9. [Progestational agents and bone metastasis in breast cancer].
Leriche N; Bonneterre J
Bull Cancer; 1997 Sep; 84(9):891-4. PubMed ID: 9435812
[TBL] [Abstract][Full Text] [Related]
10. [Hormonal control of disseminated breast cancer].
Voznyĭ EK; Meshcheriakova NG; Biakhov MIu; Vasiuta NIu
Sov Med; 1990; (6):94-7. PubMed ID: 2144368
[No Abstract] [Full Text] [Related]
11. Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women.
Gibson LJ; Dawson C; Lawrence DH; Bliss JM
Cochrane Database Syst Rev; 2007 Jan; (1):CD003370. PubMed ID: 17253488
[TBL] [Abstract][Full Text] [Related]
12. Emerging role of aromatase inhibitors in the treatment of breast cancer.
Harvey HA
Oncology (Williston Park); 1998 Mar; 12(3 Suppl 5):32-5. PubMed ID: 9556789
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial comparing aminoglutethimide with high-dose medroxyprogesterone acetate in therapy for advanced breast carcinoma.
Canney PA; Priestman TJ; Griffiths T; Latief TN; Mould JJ; Spooner D
J Natl Cancer Inst; 1988 Sep; 80(14):1147-51. PubMed ID: 2970555
[TBL] [Abstract][Full Text] [Related]
14. Second-line hormonotherapy for breast cancer. Uselessness of first-line continuation.
Pronzato P; Rubagotti A; Amoroso D; Bertelli G; Queirolo P; Sertoli MR; Rosso M; Gallotti P; Monzeglio C; Rosso R
Am J Clin Oncol; 1993 Dec; 16(6):522-5. PubMed ID: 8256770
[TBL] [Abstract][Full Text] [Related]
15. Cross-over comparison of tamoxifen and aminoglutethimide in advanced breast cancer.
Harvey HA; Lipton A; White DS; Santen RJ; Boucher AE; Shafik AS; Dixon RJ
Cancer Res; 1982 Aug; 42(8 Suppl):3451s-3453s. PubMed ID: 6177405
[TBL] [Abstract][Full Text] [Related]
16. [Aminoglutethimide in the treatment of metastasizing breast carcinoma in old age].
Gorgone S; Lorenzini C; Palmeri R; Belnome N; Calbo L; Dattola P; Melita P
Chir Ital; 1987 Apr; 39(2):166-75. PubMed ID: 3652316
[TBL] [Abstract][Full Text] [Related]
17. [Which hormone therapy should be used in advanced breast carcinoma in males?].
Lönning PE; Wiedemann G; Kvinnsland S; Lundgren S
Dtsch Med Wochenschr; 1988 Sep; 113(35):1358-61. PubMed ID: 2970379
[TBL] [Abstract][Full Text] [Related]
18. A clinical trial of aminoglutethimide in advanced postmenopausal breast carcinoma: low response in patients previously treated with medroxyprogesterone.
Alberto P; Mermillod B; Kaplan E; Goldhirsch A; Obrecht JP; Jungi F; Martz G; Barrelet L; Cavalli F
Eur J Cancer Clin Oncol; 1985 Apr; 21(4):423-8. PubMed ID: 3891359
[TBL] [Abstract][Full Text] [Related]
19. Novel endocrine therapies in breast cancer.
Klijn JG; Setyono-Han B; Bontenbal M; Seynaeve C; Foekens J
Acta Oncol; 1996; 35 Suppl 5():30-7. PubMed ID: 9142962
[TBL] [Abstract][Full Text] [Related]
20. Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis.
Mauri D; Pavlidis N; Polyzos NP; Ioannidis JP
J Natl Cancer Inst; 2006 Sep; 98(18):1285-91. PubMed ID: 16985247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
